NASDAQ:BLGO

BioLargo Stock Forecast, Price & News

$0.18

+0.02 (+12.50 %)

(As of 02/24/2021 12:00 AM ET)

Add

Compare

Today's Range

$0.17

Now: $0.18▼

$0.19

50-Day Range

$0.14

MA: $0.18▼

$0.25

52-Week Range

$0.10

Now: $0.18▼

$0.35

Volume739,111 shs

Average Volume1.05 million shs

Market Capitalization$41.56 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

BioLargo, Inc. provides technology-based products and environmental engineering solutions in the United States. The company operates through Odor-No-More, BLEST, BioLargo Water, and Clyra Medical segments. Its Advanced Oxidation System (AOS) platform is a water treatment system for decontamination and disinfection. The company offers odor and volatile organic compound control products, and AOS water treatment technologies, as well as professional engineering and consulting services. In addition, it offers wound care products for traumatic injury, diabetic ulcers, and chronic hard-to-heal wounds, as well as offers stem cell therapy, under SkinDisc brand. The company provides its products under the CupriDyne Clean and Nature's Best Science brand names. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.

Headlines

BioLargo Answers Administration's Urgent Call for Mitigation of PFAS Forever Chemicals
February 24, 2021 | finance.yahoo.com

BioLargo, Inc.: BioLargo's ONM Environmental Acquires EcoMist Trash Receptacle Spray Technology
February 8, 2021 | finanznachrichten.de

BioLargo's ONM Environmental Acquires EcoMist Trash Receptacle Spray Technology
February 8, 2021 | finance.yahoo.com

BioLargo, Inc.: BioLargo and Garratt-Callahan Team Up for Product Development Project
February 2, 2021 | finanznachrichten.de

BioLargo and Garratt-Callahan Team Up for Product Development Project
February 2, 2021 | finance.yahoo.com

Small Cap Chemical Company Up Big After Lab Analysis
January 26, 2021 | baystreet.ca

BioLargo's AEC Removal of Forever Chemicals PFAS is Confirmed 99.995% Effective in Lab Analysis Performed at the University of Tennessee
January 26, 2021 | finance.yahoo.com

BioLargo, Inc.: BioLargo Generates Record Revenue in 2020
January 25, 2021 | finanznachrichten.de

BioLargo Generates Record Revenue in 2020
January 25, 2021 | finance.yahoo.com

BioLargo, Inc.: BioLargo Completes Manufacture of First Commercial-Scale AOS Unit for Municipal Wastewater Treatment Plant
January 19, 2021 | finanznachrichten.de

BioLargo Completes Manufacture of First Commercial-Scale AOS Unit for Municipal Wastewater Treatment Plant
January 19, 2021 | finance.yahoo.com

BioLargo Discusses 2021 Goals for Growth with The Stock Day Podcast
January 6, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Chemicals

Sub-IndustryN/A

SectorBasic Materials

Current SymbolNASDAQ:BLGO

Previous Symbol

CUSIPN/A

CIK880242

Webwww.biolargo.com

Phone949 643 9540

Employees23

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares230,862,000

Market Cap$41.56 million

Next Earnings DateN/A

OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.42 out of 5 stars

Basic Materials Sector

681st out of 830 stocks

Chemicals Industry

14th out of 16 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for BioLargo.

2.1 Community Rank

Outperform Votes
BioLargo has received 102 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
BioLargo has received 142 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
BioLargo has received 58.20% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about BioLargo and other stocks. Vote “Outperform” if you believe BLGO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BLGO will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
BioLargo does not currently pay a dividend.
Dividend Growth
BioLargo does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, BioLargo insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

$0.18

+0.02 (+12.50 %)

(As of 02/24/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive BLGO News and Ratings via Email

Sign-up to receive the latest news and ratings for BLGO and its competitors with MarketBeat's FREE daily newsletter.

BioLargo (NASDAQ:BLGO) Frequently Asked Questions

What stocks does MarketBeat like better than BioLargo?

Wall Street analysts have given BioLargo a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but BioLargo wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has BioLargo's stock price been impacted by Coronavirus (COVID-19)?

BioLargo's stock was trading at $0.1910 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BLGO shares have decreased by 5.8% and is now trading at $0.18.
View which stocks have been most impacted by COVID-19.

Who are BioLargo's key executives?

BioLargo's management team includes the following people:

Mr. Dennis P. Calvert, Chairman, Pres & CEO (Age 58, Pay $322.01k)
Mr. Charles K. Dargan II, C.F.A., Chief Financial Officer (Age 66)
Mr. Joseph L. Provenzano, Exec. VP of Operations, Corp. Sec. & Director (Age 52, Pay $183.71k)
Mr. Kenneth Reay Code, Chief Science Officer & Director (Age 74, Pay $301.2k)
Mr. Steven V. Harrison II, Pres of Clyra Medical Technologies (Age 62)
Dr. Tanya Rhodes Ph.D., Chief Technology Officer of Clyra Medical Technologies
Ms. Shawn Dougherty, Chief Bus. Officer
Mr. Randall Moore, Pres of BioLargo Engineering, Science & Technologies
Dr. Richard Smith, Pres of BioLargo Water

Who are some of BioLargo's key competitors?

Some companies that are related to BioLargo include Hardide plc (HDD.L) (HDD), good natured Products Inc. (GDNP.V) (GDNP), 6211 (ETI), Advance NanoTek (ANO), Altech Chemicals (ATC), Fuchs Petrolub (FPE), Ganfeng Lithium (GNENF), good natured Products (SLGBF), HaloSource (HALO), Hazer Group (HZR), Lenzing Aktiengesellschaft (LNZNF), Linde (LNAGF), Mitsubishi Chemical (MTLHF), NanoXplore (NNXPF) and Nexeo Solutions (NXEOU).
View all of BLGO's competitors.

What other stocks do shareholders of BioLargo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioLargo investors own include Micron Technology (MU), The Liberty Braves Group (BATRA), CV Sciences (CVSI), FuelCell Energy (FCEL), International Business Machines (IBM), ProShares UltraPro Short Russell2000 (SRTY), Tencent (TCEHY), ASML (ASML), Arotech (ARTX) and Ameresco (AMRC).

What is BioLargo's stock symbol?

BioLargo trades on the NASDAQ under the ticker symbol "BLGO."

How do I buy shares of BioLargo?

Shares of BLGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BioLargo's stock price today?

One share of BLGO stock can currently be purchased for approximately $0.18.

How much money does BioLargo make?

BioLargo has a market capitalization of $41.56 million.

How many employees does BioLargo have?

BioLargo employs 23 workers across the globe.

What is BioLargo's official website?

The official website for BioLargo is www.biolargo.com.

How can I contact BioLargo?

The company can be reached via phone at 949 643 9540.

This page was last updated on 2/24/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here